BRVE (Braveheart Bio) FCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BRVE Braveheart Bio Inc BRVE
8 GF Score
Price $31.93
View Full Analysis

What is Braveheart Bio FCF Margin %?

Braveheart Bio BRVE -2.72% 8 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates BRVE with a GF Score™ of 8/100. Among 954 Biotechnology companies, Braveheart Bio ranks worse than 104821.7% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Braveheart Bio's Free Cash Flow for the six months ended in Dec. 2025 was $-35.58 Mil. Braveheart Bio's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Braveheart Bio's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Braveheart Bio's current FCF Yield % is -16,900.00%.

The historical rank and industry rank for Braveheart Bio's FCF Margin % or its related term are showing as below:


BRVE's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -77.785
* Ranked among companies with meaningful FCF Margin % only.

Braveheart Bio FCF Margin % Related Terms

Braveheart Bio FCF Margin % Historical Data

* Premium members only.

The historical data trend for Braveheart Bio's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Braveheart Bio FCF Margin % Chart

Braveheart Bio Annual Data
Trend Dec25
FCF Margin %
0.00

Braveheart Bio Semi-Annual Data
Dec25
FCF Margin % 0.00

BRVE vs : FCF Margin % Comparison

For the Biotechnology subindustry, Braveheart Bio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Braveheart Bio FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Braveheart Bio's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Braveheart Bio's FCF Margin % falls into.


BRVE
8GF Score
Braveheart Bio Inc BRVE
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Braveheart Bio FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Braveheart Bio's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-35.583/0
= %

Braveheart Bio's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-35.583/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Braveheart Bio (BRVE) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Braveheart Bio and its competitors. According to the industry distribution chart, Braveheart Bio ranks #999999 out of 954 companies in the Biotechnology industry.
Is Braveheart Bio's FCF Margin % too high?
Braveheart Bio's current FCF Margin % is 0.00%. Based on the distribution chart, Braveheart Bio ranks #999999 out of 954 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Braveheart Bio has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Braveheart Bio's FCF Margin % compare to ?
According to the Biotechnology industry distribution chart, Braveheart Bio ranks #999999 out of 954 companies for FCF Margin %. This places Braveheart Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Braveheart Bio and its competitors. Braveheart Bio's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Braveheart Bio stock overvalued right now?
Braveheart Bio (BRVE) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Braveheart Bio's overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Braveheart Bio (BRVE), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Braveheart Bio Business Description

Comparable Companies
Address One Letterman Drive, Suite A4-300, Building A, San Francisco, CA, USA, 94129
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).
8GF Score

Get the complete analysis for BRVE

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.93
Price